Transfer hydrogenation process and catalyst
AssigneeNPIL Pharmaceuticals (UK) Limited
InventorsAndrew John Blacker, Christian Bubert, Jonathan Michael Jeremy Williams, Stephen Martin Brown
Life of this patent
Estimating the term…
Loading patent…
AssigneeNPIL Pharmaceuticals (UK) Limited
InventorsAndrew John Blacker, Christian Bubert, Jonathan Michael Jeremy Williams, Stephen Martin Brown
Estimating the term…
A catalytic transfer hydrogenation process is provided. The catalyst employed in the process is a metal hydrocarbyl complex which is coordinated to defined bidentate ligands substituted with at least one group selected from an optionally substituted sulphonated hydrocarbyl group, a sulphonated perhalogenated hydrocarbyl group, or an optionally substituted sulphonated heterocyclyl group. Preferred metals include rhodium, ruthenium and iridium. Preferred bidentate ligands are diamines and aminoalcohols, particularly those comprising chiral centres. The hydrogen donor is advantageously a secondary alcohol or a mixture of triethylamine and formic acid. The process can be employed to transfer hydrogenate ketones and imines, which are preferably prochiral. Catalysts for use in such a process are also provided.
A catalyst having the general formula:
A ligand having the following formula:
The compound:
The compound:
The compound:
The compound:
A process comprising reacting a di-sulphide of formula:
A process for the transfer hydrogenation of an organic compound having a carbon-carbon or carbon-heteroatom double bond,
Dependencies are inferred from the claim text.